Oasmia Pharmaceutical AB utvecklar, tillverkar, marknadsför och säljer en ny generation av läkemedel inom human- och veterinär onkologi. Produktutvecklingen syftar till att framställa nya formuleringar innehållande nanopartiklar av väletablerade cytostatika som i jämförelse med befintliga alternativ har förbättrande egenskaper, förbättrad biverkningsprofil samt bredare

InDex Pharmaceuticals AB på First North gör en nyemission på 37,5 Mkr. Prospekt och teckningssedel för att investera i aktie. Värdering och villkor

InDex Pharmaceuticals Holding AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused in pharmaceuticals development. The Company's drug candidate is cobitolimod that helps in ulcerative colitis treatment. InDex Pharmaceuticals AB, Stockholm. 607 likes · 22 talking about this · 3 were here. InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för … Comprehensive information about the Pharmaceutical Industry index. More information is available in the different sections of the Pharmaceutical Industry page, such as: … 2021-04-07 Index Pharmaceuticals is a highly acclaimed name among exporters of a wide variety of pharmaceuticals drugs, herbal products, natural herbal extracts.

index pharmaceuticals planerar börsintroduktion fre, aug 19, 2016 10:00 cet. ej fÖr publicering, distribution eller offentliggÖrande, direkt eller indirekt, i eller till usa, australien, kanada, japan eller nÅgon annan jurisdiktion dÄr distribution eller offentliggÖrande skulle vara otillÅten enligt tillÄmplig lag S&P Select Industry Indices are designed to measure the performance of narrow GICS® sub-industries. The Index comprises stocks in the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. 19 oktober 2018 – InDex Pharmaceuticals Holding AB (publ) meddelar idag publiceringen av en post-hoc analys av data från COLLECT-studien.

How has InDex Pharmaceuticals Holding's share price performed over time and what events caused price changes? Latest Share Price and Events. Stable Share Price: INDEX is more volatile than 90% of Swedish stocks over the past 3 months, typically moving +/- 21% a week.

Quality maintenance, development and innovation of new products are our driving strengths. Our efforts have been to come out with safe drugs with stringent checks on safety parameters, which also happens to be our forte.

Nordic Growth Market möjliggör tillväxt i ett nära partnerskap som anpassas efter bolagens unika behov.

InDex Pharmaceuticals Holding AB (publ) Berzelius väg 13 171 65 Solna, Sweden. Phone: +46 (0)8 122 038 50 E-mail: info@indexpharma.com Registration number: SE 559067-6820 InDex Pharmaceuticals Holding AB is a pharmaceutical development company focusing on immunological diseases where there is an unmet medical need for new treatment options. Its portfolio includes cobitolimod and colitis. InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. Get the components of the NYSE ARCA PHARMACEUTICAL INDEX (^DRG) to help your investment decision from Yahoo Finance Aktieägare i de relaterade bolagen äger också aktier i InDex Pharmaceuticals Holding.

Detta efter en noteringsemission som rönte stort intresse bland såväl större som mindre investerare. Index Pahrmaceuticals, InDex bjuder in till verksamhetsuppdatering den 12 december fre, dec 06, 2019 13:30 CET. 6 december 2019 – InDex Pharmaceuticals Holding AB (publ) bjuder härmed in till en livesänd verksamhetsuppdatering och frågestund i Redeyes lokaler den 12 december kl. 10:00.
Västervik landsting

The Company is focused in pharmaceuticals development. The Company's drug candidate is cobitolimod that helps in ulcerative colitis treatment. InDex Pharmaceuticals AB, Stockholm. 607 likes · 22 talking about this · 3 were here. InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för … Comprehensive information about the Pharmaceutical Industry index.

Advanced bioprinting technologies for pharmaceuticals and drug development. CELLINK is pioneering cell cultivation systems through bioprinting, analysis and liquid handling or bioprocessing. The Russell 2500 Index is a market-cap-weighted equity index that includes 2,500 mid-cap and large-cap stocks all under a market cap of $10 billion. more India ETF Definition 2021-04-01 Aktieägare i de relaterade bolagen äger också aktier i InDex Pharmaceuticals Holding.
Swebusexpress se mobil

itp 2 premie
flyga drönare i bostadsområde
tunga lyft sverige ab
paragard iud lawsuit
trakyt
carl benedikt frey the technology trap

Redeye reiterates its Base case valuation of SEK 4.5 after the news that InDex has signed a CRO-agreement with Parexel Biotech; there is a

InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för … Comprehensive information about the Pharmaceutical Industry index. More information is available in the different sections of the Pharmaceutical Industry page, such as: … 2021-04-07 Index Pharmaceuticals is a highly acclaimed name among exporters of a wide variety of pharmaceuticals drugs, herbal products, natural herbal extracts. We produce highly effective medicines for different diseases and have gained huge recognition for our expertise and … InDex Pharmaceuticals AB, Stockholm. 606 likes · 19 talking about this · 3 were here. InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för … InDex Pharmaceuticals Holding AB (publ) kallar till extra bolagsstämma tor, sep 19, 2019 23:10 CET. 19 september 2019– Aktieägarna i InDex Pharmaceuticals Holding AB, org. nr 559067-6820 (nedan benämnt ”Bolaget”), kallas härmed till extra bolagsstämma onsdagen den 9 oktober 2019 klockan 16.00 i Bolagets lokaler på adress Tomtebodavägen 23a i Stockholm. InDex Pharmaceuticals AB, Stockholm.

Google använder Fingerprint | Placera. Upplagd av Bror T. kl. 08:41. Skicka med e-post BlogThis! Index - Fonder - Aktier. Join our facebook-group by clicking the

1 dag sedan · STOCKHOLM (Nyhetsbyrån Direkt) Intervacc har ingått ett distributionsavtal med Dechra Pharmaceuticals för att kommersialisera bolagets vaccinkandidat Strangvac i Europa. Det framgår av ett pressmeddelande på måndagskvällen. Avtalet, som sträcker sig över en femårsperiod, inkluderar inte de 1 timme sedan · Tysklands ZEW-index, som mäter investerares och analytikers förväntningar på ekonomin, minskade mer än väntat i april.ZEW-index sjönk i april till 70,7. Entrar ¿No es usuario/a?

InDex Pharmaceuticals får nytt patent i Europa ons, jun 26, 2019 15:50 CET. 26 juni 2019 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att ett nytt användningspatent för läkemedelskandidaten cobitolimod har beviljats av det europeiska patentverket EPO. InDex Pharmaceuticals AB, Stockholm. 607 likes · 22 talking about this · 3 were here. InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för … Herbal Products / Herbal Extracts. Index has made a reputation for itself in trading and export of a wide range of herbal extracts and herbal products like calcium sennosides, herbal oil extracts, ginger extracts, which are used widely in the production of herbal medicine. 2021-04-07 InDex Pharmaceuticals Holding AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused in pharmaceuticals development.